Risk of neuropsychological impairment among therapeutic community residents: relationship with dropout and spontaneous recovery during treatment

治疗社区居民神经心理损伤风险:与治疗期间的退出和自发恢复的关系

阅读:1

Abstract

BACKGROUND: Therapeutic Communities (TCs) are long-term residential treatment settings for individuals with substance use disorders, who often present with neuropsychological impairments. These impairments may influence treatment retention, yet little is known about their evolution in TCs or their association with dropout. This study aims to: (1) identify early risk factors for dropout; (2) investigate the potential recovery from the risk of neuropsychological impairment during an 8-mont stay in a TC; and 3) identify variables at TC entry that may predict the risk of neuropsychological impairment during follow-up. METHODS: Fifty-seven residents from 3 French TCs completed clinical, substance use, and medical assessments, along with a neuropsychological screening (BEARNI) at entry. Twenty-four completed the 8-month follow-up. RESULTS: The dropout rate was 47%. The only significant predictor of dropout was the BEARNI total score, with residents at lower risk of neuropsychological impairment more likely to leave the TC prematurely. Among completers, BEARNI total scores improved at follow-up, primarily explained by improvements in balance rather than in cognitive areas. Lower education, unemployment, recent alcohol use, depressive symptoms, and a history of hepatic disease were consistently associated with a higher risk of neuropsychological impairment at both time points. CONCLUSIONS: Unlike other treatment settings, the TC care framework may be particularly appropriate and supportive for residents who are more cognitively vulnerable, as they may be better able to benefit from TCs. Motor recovery among those who remain in treatment is encouraging. However, demographic, addiction-related, and comorbidity factors are consistently associated with the risk of neuropsychological impairment, both at baseline and after 8 months, suggesting a stable and persistent influence over time. CLINICAL TRIAL NUMBER: Not applicable.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。